Mindera Health, based in Vista, US, develops precision medicine tests for dermatological conditions, focused on psoriasis.
Founded in 2013 and headquartered in Vista, US, Mindera Health develops precision medicine for dermatology, mainly the Mind.Px test for psoriasis, a non-invasive patch that collects RNA transcripts from the skin. Test results inform treatment decisions for patients on biologics, and the test is sold to healthcare providers on a business-to-business basis. The company has raised a total of USD 12.00 mn, including a Series A in May 2021 co-led by Mountain Group Partners, Rockmont Capital Partners and Scientific Health Development. CEO George Mahaffey leads the company.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in